FDA Approves Clinical Trial of Novel Stem Cell and Gene Therapy to Stall Progression of ALS – Yahoo Sports
|
FDA Approves Clinical Trial of Novel Stem Cell and Gene Therapy to Stall Progression of ALS
Yahoo Sports This study is the first clinical trial to use neural stem cells to deliver GDNF for ALS, an approach developed by Clive Svendsen, Ph.D., from Cedars-Sinai. It will be conducted at the ALS clinic at Cedars-Sinai Medical Center and led by Robert Baloh, M … |
